These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16969919)

  • 1. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Packer CS; Pelaez NJ
    J Appl Physiol (1985); 2006 Sep; 101(3):1001; author reply 1004-5. PubMed ID: 16969919
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Aaronson PI
    J Appl Physiol (1985); 2006 Sep; 101(3):1000; author reply 1004-5. PubMed ID: 16902073
    [No Abstract]   [Full Text] [Related]  

  • 3. Counterpoint: Hypoxic pulmonary vasoconstriction is not mediated by increased production of reactive oxygen species.
    Weir EK; Archer SL
    J Appl Physiol (1985); 2006 Sep; 101(3):995-8; discussion 998. PubMed ID: 16902070
    [No Abstract]   [Full Text] [Related]  

  • 4. Point: Hypoxic pulmonary vasoconstriction is mediated by increased production of reactive oxygen species.
    Ward JP
    J Appl Physiol (1985); 2006 Sep; 101(3):993-5; discussion 999. PubMed ID: 16675614
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Evans AM; Gonzalez C
    J Appl Physiol (1985); 2006 Sep; 101(3):1001-2; author reply 1004-5. PubMed ID: 16969920
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Gupte SA; Wolin MS
    J Appl Physiol (1985); 2006 Sep; 101(3):1000-1; author reply 1004-5. PubMed ID: 16969918
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.
    Berchner-Pfannschmidt U; Acker H; Fandrey J
    J Appl Physiol (1985); 2006 Sep; 101(3):1000; author reply 1004-5. PubMed ID: 16969917
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxic pulmonary vasoconstriction: role of ion channels.
    Mauban JR; Remillard CV; Yuan JX
    J Appl Physiol (1985); 2005 Jan; 98(1):415-20. PubMed ID: 15591311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic pulmonary vasoconstriction: ups and downs of reactive oxygen species.
    Sham JS
    Circ Res; 2002 Oct; 91(8):649-51. PubMed ID: 12386138
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoxic pulmonary vasoconstriction.
    Moudgil R; Michelakis ED; Archer SL
    J Appl Physiol (1985); 2005 Jan; 98(1):390-403. PubMed ID: 15591309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing.
    Waypa GB; Schumacker PT
    J Appl Physiol (1985); 2005 Jan; 98(1):404-14. PubMed ID: 15591310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic pulmonary vasoconstriction: a radical view.
    Sylvester JT
    Circ Res; 2001 Jun; 88(12):1228-30. PubMed ID: 11420297
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensors and signals: the role of reactive oxygen species in hypoxic pulmonary vasoconstriction.
    Smith KA; Schumacker PT
    J Physiol; 2019 Feb; 597(4):1033-1043. PubMed ID: 30091476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic pulmonary vasoconstriction--triggered by an increase in reactive oxygen species?
    Weissmann N; Schermuly RT; Ghofrani HA; Hänze J; Goyal P; Grimminger F; Seeger W
    Novartis Found Symp; 2006; 272():196-208; discussion 208-17. PubMed ID: 16686437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction.
    Frazziano G; Moreno L; Moral-Sanz J; Menendez C; Escolano L; Gonzalez C; Villamor E; Alvarez-Sala JL; Cogolludo AL; Perez-Vizcaino F
    J Cell Physiol; 2011 Oct; 226(10):2633-40. PubMed ID: 21792922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expression.
    Tsai BM; Lahm T; Morrell ED; Crisostomo PR; Poynter J; Wang M; Meldrum DR
    J Surg Res; 2008 Mar; 145(1):130-4. PubMed ID: 17574585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox activation of intracellular calcium release channels (ryanodine receptors) in the sustained phase of hypoxia-induced pulmonary vasoconstriction.
    Du W; Frazier M; McMahon TJ; Eu JP
    Chest; 2005 Dec; 128(6 Suppl):556S-558S. PubMed ID: 16373824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic pulmonary hypertension: acute and chronic.
    Thompson BT; Hales CA
    Heart Lung; 1986 Sep; 15(5):457-65. PubMed ID: 3639074
    [No Abstract]   [Full Text] [Related]  

  • 19. Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia.
    Archer SL; Hampl V; Nelson DP; Sidney E; Peterson DA; Weir EK
    Circ Res; 1995 Jul; 77(1):174-81. PubMed ID: 7788875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic pulmonary vasoconstriction and regional and whole-lung PEEP in the dog.
    Benumof JL; Rogers SN; Moyce PR; Berryhill RE; Wahrenbrock EA; Saidman LJ
    Anesthesiology; 1979 Dec; 51(6):503-7. PubMed ID: 391103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.